World

ECDC situation report on outbreak of influenza A(H1N1) 11 Dec 2009

Format
Situation Report
Source
Posted
Originally published
Origin
View original

Attachments

Main developments in the past 24 hours

- Weekly Influenza Surveillance Overview to be published today;

- Eurosurveillance updates published;

- A total of 1 227 fatal cases in Europe and EFTA countries and 9 340 in the rest of the world have been reported up to date.

This report is based on official information provided by national public health websites or through other official communication channels.

Reported number of confirmed Pandemic (H1N1) 2009 influenza cases admitted to hospitals and intensive care, by country, as of 11 December 2009, 9.00 CEST in EU and EFTA countries are in Table 1. An update on the number of confirmed fatal cases for the world and Europe is presented in Table 2.

Eurosurveillance update

Public perceptions in relation to intention to receive pandemic influenza vaccination in a random population sample: evidence from a cross-sectional telephone survey

A cross-sectional telephone survey on a nationally representative sample of 1,000 Greek households was performed to assess the acceptability of the pandemic influenza A(H1N1)v vaccine, factors associated with intention to decline and stated reasons for declining vaccination. The survey was initiated the last week of August 2009 (week 35) and is still ongoing (analysis up to week 44). The percentage of participants answering they would "probably not/definitely not" accept the vaccine increased from 47.1% in week 35 to 63.1% in week 44 (test for trend: p<0.001). More than half of the people which chronic illnesses (53.3%) indicated "probably not/definitely not". Factors associated with intention to decline vaccination were female sex, age between 30-64 years, perception of low likelihood of getting infected or of low risk associated with influenza, and absence of household members suffering from chronic illnesses. For the majority of the respondents (59.8%), the main reason for intending to decline vaccination was the belief that the vaccine might not be safe. Promotion of vaccination programmes should be designed taking into account the attitudinal barriers to the pandemic vaccine.

Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19437